Moreover, as for IL-12 cytokines, a study indicated no evidence of CTCL relation with IL-23 biological therapies [159], despite some case reports [208] and small patient series [209]. This evidence concerns the gene IL23A and primary cutaneous T-cell non-Hodgkin lymphoma.